Dapoxetine Hydrochloride CAS 129938-20-1 Assay ≥99.0% API Ụlọ ọrụ dị elu

Nkọwa dị mkpirikpi:

Aha kemịkal: Dapoxetine Hydrochloride

Ọnọdụ: 129938-20-1

Ọdịdị: Ọcha ka ọ fọrọ nke nta ka ọ bụrụ ọcha kristal ntụ ntụ

Nyocha: ≥99.0%

Ndị na-egbochi SSRI iji gwọọ ejaculation na-akaghị aka (PE) n'ime ụmụ nwoke

API Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Dapoxetine Hydrochloride na-eweta azụmaahịa yana ihe ndị metụtara ya:
3-Chloropropiophenone CAS: 936-59-4
(S)-3-Amino-3-Phenylpropan-1-ol CAS: 82769-76-4
(S)-3-Amino-3-Phenylpropanoic Acid CAS: 40856-44-8
(R) - Diphenylprolinol CAS: 22348-32-9
(S) -Diphenylprolinol CAS: 112068-01-6
(S)-(-)-3-Chloro-1-Phenyl-1-Propanol CAS: 100306-34-1
Dapoxetine Hydrochloride CAS: 129938-20-1

Njirimara kemịkalụ:

Aha Chemical	Dapoxetine Hydrochloride
Ụdị okwu	Dapoxetine HCl;LY-210448 Hydrochloride;Priligion;(S) -N, N-Dimethyl-3- (1-naphthyloxy) -1-phenylpropylamine Hydrochloride.
Nọmba CAS	129938-20-1
Nọmba CAT	RF-API92
Ọnọdụ Ahịa	Na Akụrụngwa, Mpụta Ihe ruru narị narị kilograms
Usoro ihe omimi	C21H23NO-HCl
Ibu molekụla	341.88
Okpomọkụ nchekwa	Okpomọkụ ụlọ
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Ọcha ka ọ fọrọ nke nta ka ọ bụrụ ọcha kristal ntụ ntụ
njirimara	IR
Nyocha	≥99.0%
Ebe Na-agbaze	175.0-182.0 ℃
Ọnwụ na ihicha	≤1.0%
Ihe fọdụrụ na mgbanye	≤0.10%
Ntụgharị akọwapụtara	+126.0°~130.0°(C=1, CH3OH)
Ọla dị arọ	≤10ppm
Chromatographic adịghị ọcha
Otu adịghị ọcha	≤0.20%
Mgbakọta adịghị ọcha	≤1.0%
Ihe mgbaze fọdụrụnụ	Na-emezu ihe achọrọ
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	API, SSRI Inhibitor maka ọgwụgwọ nke Mgbapụta Ọsọ (PE) n'ime ụmụ nwoke

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.

Uru:

Ajụjụ:

Ngwa:

Dapoxetine Hydrochloride (CAS 129938-20-1) bụ ọgwụ mbụ, onye na-eme ihe na-eme ihe dị mkpụmkpụ nke na-eme ihe na-emechi ihe nchịkwa serotonin reuptake (SSRI) nke a na-ere maka ọgwụgwọ nke ejaculation akaghi aka na ụmụ nwoke 18-64.Ejaculation akaghi aka (PE) bụ nsogbu mmekọahụ nke nwoke na-enwekarị, nke e mere atụmatụ na ọ na-emetụta ihe ruru 30% nke ụmụ nwoke.A na-anabatakarị ọgwụgwọ dapoxetine nke ọma, na-enwe mmetụta dị ala nke ọrịa nkwụsịtụ, nkwụsịtụ mmekọahụ, na ọgwụgwọ-mgbaàmà ọnọdụ ọnọdụ mberede.Dapoxetine na-arụ ọrụ site na igbochi onye na-ebugharị serotonin, na-abawanye ọrụ serotonin na post synaptic cleft, yana n'ihi ya na-akwalite igbu oge ejaculatory.Dị ka onye so n'ezinụlọ serotonin reuptake inhibitor (SSRI), a na-emepụta dapoxetine na mbụ dị ka antidepressant.Otú ọ dị, n'adịghị ka SSRI ndị ọzọ, a na-etinye dapoxetine ma kpochapụ ngwa ngwa n'ime ahụ.Ngwongwo ya na-eme ngwa ngwa na-eme ka ọ dị mma maka ọgwụgwọ PE ma ọ bụghị dị ka antidepressant.